M&A Deal Summary

Sensei Acquires Alvaxa Biosciences

On May 27, 2020, Sensei acquired life science company Alvaxa Biosciences

Acquisition Highlights
  • This is Sensei’s 1st transaction in the Life Science sector.
  • This is Sensei’s 1st transaction in the United States.
  • This is Sensei’s 1st transaction in Washington.

M&A Deal Summary
Date 2020-05-27
Target Alvaxa Biosciences
Sector Life Science
Buyer(s) Sensei
Deal Type Add-on Acquisition

Target

Alvaxa Biosciences

Seattle, Washington, United States
Alvaxa Biosciences is a camelid antibody therapeutics company with technology licensed from Fred Hutchinson Cancer Research Center. The company develops camelid antibodies, or nanobodies, through a partnership with Hope Farms, LLC, a United States Department of Agriculture (USDA) licensed Alpaca farm. Alvaxa Biosciences is based in Seattle, Washington.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Sensei

Rockville, Maryland, United States
Category Company
Founded 1999
Sector Life Science
Employees28
Revenue 37M USD (2023)
DESCRIPTION

Sensei is a clinical-stage biopharmaceutical company focused on the discovery, development, and delivery of precision immuno-oncology therapies to transform the cancer treatment landscape. Sensei was formed in 1999 and is based in Rockville, Maryland.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Washington) 1 of 1
Country (United States) 1 of 1
Year (2020) 1 of 1
Mergr

Product

Company

Legal